Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action

被引:48
作者
Zhu, Ting-Ge [1 ]
Wang, Xiao-Xia [2 ]
Luo, Wei-Feng [1 ,3 ]
Zhang, Qi-Lin [1 ]
Huang, Ting-Ting [1 ]
Xu, Xing-Shun [3 ]
Liu, Chun-Feng [1 ,3 ]
机构
[1] Soochow Univ, Dept Neurol, Affiliated Hosp 2, Suzhou 215004, Peoples R China
[2] Soochow Univ, Dept Oncol, Affiliated Hosp 2, Suzhou 215004, Peoples R China
[3] Soochow Univ, Inst Neurosci, Suzhou 215123, Peoples R China
关键词
6-Hydroxydopamine (6-OHDA); Urate; Oxidative stress; Parkinson's disease; PARKINSONS-DISEASE; URIC-ACID; NITRIC-OXIDE; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; RISK; DAMAGE; SERUM; NEUROTOXICITY; INHIBITION;
D O I
10.1016/j.neulet.2011.10.075
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is evidence to support that oxidative stress is increased in Parkinson's disease (PD) and contributes to the degeneration of dopaminergic neurons. Recent research has shown that higher blood urate concentrations have now been linked to decreased risks and progression rates of PD. However, the mechanisms about urate to protect dopaminergic neurons are less clear. Our study investigated the effect of urate on oxidative stress induced by 6-hydroxydopamine (6-OHDA) in neuronal differentiated PC12 cells. We found that urate significantly reduced 6-OHDA-induced lactate dehydrogenas (LDH), malondialdehyde (MDA), and 8-hydroxy-deoxyguanosine (8-OHdG) generation but increased the superoxide dismutase (SOD) activity and glutathione (GSH) levels in the PC12 cells. These results suggested that urate can prevent PC12 cells from oxidative injury induced by 6-OHDA, which may play an important role in the mechanisms underlying the association of high plasma levels of urate with reduced risk and slower progression of PD. Urate treatment could be a potential therapeutic strategy for PD. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 28 条
  • [1] Oxidative stress and gene regulation
    Allen, RG
    Tresini, M
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (03) : 463 - 499
  • [2] Gout and risk of Parkinson disease -: A prospective study
    Alonso, Alvaro
    Garcia Rodriguez, Luis A.
    Logroscino, Giancarlo
    Hernan, Miguel A.
    [J]. NEUROLOGY, 2007, 69 (17) : 1696 - 1700
  • [3] Gout, hyperuricemia, and Parkinson's disease: A protective effect?
    Alonso A.
    Sovell K.A.
    [J]. Current Rheumatology Reports, 2010, 12 (2) : 149 - 155
  • [4] Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
    Alvarez-Fischer, Daniel
    Guerreiro, Serge
    Hunot, Stephane
    Saurini, Francoise
    Marien, Marc
    Sokoloff, Pierre
    Hirsh, Etienne C.
    Hartmann, Andreas
    Michel, Patrick P.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2008, 107 (03) : 701 - 711
  • [5] Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration
    Andreadou, Elisabeth
    Nikolaou, Chryssoula
    Gournaras, Filippos
    Rentzos, Michael
    Boufidou, Fotini
    Tsoutsou, Anthoussa
    Zournas, Christos
    Zissimopoulos, Vassilis
    Vassilopoulos, Demetrios
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (09) : 724 - 728
  • [6] Low plasma uric acid level in Parkinson's disease
    Annanmaki, Tua
    Muuronen, Antti
    Murros, Kari
    [J]. MOVEMENT DISORDERS, 2007, 22 (08) : 1133 - 1137
  • [7] Generation of reactive oxygen species and 8-hydroxy-2′-deoxyguanosine formation from diesel exhaust particle components in L1210 cells
    Arimoto, T
    Yoshikawa, T
    Takano, H
    Kohno, M
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1999, 80 (01) : 49 - 54
  • [8] URIC-ACID IS REDUCED IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE - EFFECT ON DOPAMINE OXIDATION
    CHURCH, WH
    WARD, VL
    [J]. BRAIN RESEARCH BULLETIN, 1994, 33 (04) : 419 - 425
  • [9] URIC-ACID IRON-ION COMPLEXES - A NEW ASPECT OF THE ANTIOXIDANT FUNCTIONS OF URIC-ACID
    DAVIES, KJA
    SEVANIAN, A
    MUAKKASSAHKELLY, SF
    HOCHSTEIN, P
    [J]. BIOCHEMICAL JOURNAL, 1986, 235 (03) : 747 - 754
  • [10] Serum uric acid levels and the risk of Parkinson disease
    de Lau, LML
    Koudstaal, PJ
    Hofman, A
    Breteler, MMB
    [J]. ANNALS OF NEUROLOGY, 2005, 58 (05) : 797 - 800